The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 6 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Assertion Supported
Wickramasekara: Major pharma increasingly licenses drug molecules from China
“We've seen this huge uptick in pharma going to China and buying molecules that they typically would have bought from American biotechs.”
Sajith Wickramasekara Nov 13, 2025 ▶ 7:09 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Prediction Held up
Wickramasekara: GLP-1s will probably be the best-selling drugs of all time
“And then all of a sudden, like we have this category defining medicine that's going to go on to probably be the best selling drug of all, all time.”
Sajith Wickramasekara Nov 13, 2025 ▶ 15:12 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Supported
Wickramasekara: Prescription drugs account for 9% of US healthcare spending
“I think nine percent of healthcare spent, prescription drug sales are nine percent of healthcare spending in the U.S.”
Sajith Wickramasekara Nov 13, 2025 ▶ 9:44 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Supported
Wickramasekara: J&J's cancer drug Carvykti originated from China's Legend Biotech
“Johnson and Johnson partnered with a Chinese biotech called Legend Biotech... They've taken it, and it's a, it's actually a cancer immunotherapy... For multiple myeloma. And like that, that medicine is very commercially successful and widely distributed in the…”
Sajith Wickramasekara Nov 13, 2025 ▶ 7:42 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Supported
Wickramasekara: The core science behind GLP-1s has existed since the 1990s
“And so, but the core science for GLP ones was kind of sitting on the shelf in some sense, like it's been known since like the nineties.”
Sajith Wickramasekara Nov 13, 2025 ▶ 15:02 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Supported
Wickramasekara: Eli Lilly launched TuneLab to share AI models via federated learning
“Eli Lilly put out this announcement about a project they have called TuneLab, where they're taking their internal models and making them available to the broader scientific ecosystem. So a farmer company is saying, hey, you can use our models, but it's give to…”
Sajith Wickramasekara Nov 13, 2025 ▶ 24:52 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.